Novo Nordisk A/S
CSE:NOVO B
Novo Nordisk A/S
CSE:NOVO B
Price:
852.2 DKK
0.19%
Updated:
May 6, 2024
Novo Nordisk A/S
Pre-Tax Income
|
Novo Nordisk A/S
Pre-Tax Income Peer Comparison
Comparables:
HLUN A
ALK B
Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Pre-Tax Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Novo Nordisk A/S
CSE:NOVO B
|
Pre-Tax Income
kr104.7B
|
CAGR 3-Years
25%
|
CAGR 5-Years
17%
|
CAGR 10-Years
12%
|
|
|
H Lundbeck A/S
CSE:HLUN A
|
Pre-Tax Income
kr3B
|
CAGR 3-Years
16%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
ALK-Abello A/S
CSE:ALK B
|
Pre-Tax Income
kr647m
|
CAGR 3-Years
86%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Novo Nordisk A/S's Pre-Tax Income?
Pre-Tax Income
104.7B
DKK
104.7B
DKK
Based on the financial report for Dec 31, 2023, Novo Nordisk A/S's Pre-Tax Income amounts to 104.7B DKK.
What is Novo Nordisk A/S's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 10Y
12%
12%
Over the last year, the Pre-Tax Income growth was 52%. The average annual Pre-Tax Income growth rates for Novo Nordisk A/S have been 25% over the past three years , 17% over the past five years , and 12% over the past ten years .
You don't have any saved screeners yet
